cyclobenzaprine hydrochloride

Generic: cyclobenzaprine hydrochloride

Labeler: asclemed usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name cyclobenzaprine hydrochloride
Generic Name cyclobenzaprine hydrochloride
Labeler asclemed usa, inc.
Dosage Form CAPSULE, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

cyclobenzaprine hydrochloride 30 mg/1

Manufacturer
Asclemed USA, Inc.

Identifiers & Regulatory

Product NDC 76420-896
Product ID 76420-896_2b1fe790-9c6e-85ed-e063-6294a90a6471
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA091281
Listing Expiration 2026-12-31
Marketing Start 2019-03-01

Pharmacologic Class

Classes
centrally-mediated muscle relaxation [pe] muscle relaxant [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 76420896
Hyphenated Format 76420-896

Supplemental Identifiers

RxCUI
828353 828358
UNII
0VE05JYS2P

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cyclobenzaprine hydrochloride (source: ndc)
Generic Name cyclobenzaprine hydrochloride (source: ndc)
Application Number ANDA091281 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 30 mg/1
source: ndc
Packaging
  • 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (76420-896-01)
  • 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (76420-896-30)
  • 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (76420-896-60)
  • 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (76420-896-90)
source: ndc

Packages (4)

76420-896-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (76420-896-01) 76420-896-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (76420-896-30) 76420-896-60 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (76420-896-60) 76420-896-90 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (76420-896-90)

Ingredients (1)

cyclobenzaprine hydrochloride (30 mg/1)

Linked Drug Pages (1)

Cyclobenzaprine Hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2b1fe790-9c6e-85ed-e063-6294a90a6471", "openfda": {"unii": ["0VE05JYS2P"], "rxcui": ["828353", "828358"], "spl_set_id": ["3dd2bde1-f06d-493a-91c7-22b28a5e1699"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (76420-896-01)", "package_ndc": "76420-896-01", "marketing_start_date": "20250107"}, {"sample": false, "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (76420-896-30)", "package_ndc": "76420-896-30", "marketing_start_date": "20250107"}, {"sample": false, "description": "60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (76420-896-60)", "package_ndc": "76420-896-60", "marketing_start_date": "20250107"}, {"sample": false, "description": "90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (76420-896-90)", "package_ndc": "76420-896-90", "marketing_start_date": "20250107"}], "brand_name": "Cyclobenzaprine Hydrochloride", "product_id": "76420-896_2b1fe790-9c6e-85ed-e063-6294a90a6471", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Centrally-mediated Muscle Relaxation [PE]", "Muscle Relaxant [EPC]"], "product_ndc": "76420-896", "generic_name": "Cyclobenzaprine Hydrochloride", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cyclobenzaprine Hydrochloride", "active_ingredients": [{"name": "CYCLOBENZAPRINE HYDROCHLORIDE", "strength": "30 mg/1"}], "application_number": "ANDA091281", "marketing_category": "ANDA", "marketing_start_date": "20190301", "listing_expiration_date": "20261231"}